期刊文献+

糖尿病肾病患者尿微量清蛋白相关因素研究 被引量:6

Clinical Analysis of Related Factors of Microalbuminuria in Patients with Diabetic Nephropathy
下载PDF
导出
摘要 目的探讨糖尿病肾病(DN)患者尿微量清蛋白(MAU)的相关因素。方法选择2009年在新疆医科大学第一附属医院住院的377例DN患者为研究对象,回顾性分析患者的一般资料〔性别、年龄、民族、糖尿病病程、身高、体质量、体质指数(BMI)等〕及实验室检查结果〔包括尿酸(BUA)、空腹血糖(FBG)、三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、糖化血红蛋白(HbA1c)、脂蛋白〕。根据尿MAU将患者分为低值蛋白尿组、高值蛋白尿组和极高值蛋白尿组,比较3组患者上述指标间的差异,并分析各指标与尿MAU的相关性。结果 (1)与低值蛋白尿组比较,高值蛋白尿组、极高值蛋白尿组患者年龄大、病程长,BMI、FBG、BUA、TG、TC、LDL、脂蛋白水平更高,而GFR降低,差异均有统计学意义(P<0.05)。(2)多元相关分析显示,年龄、糖尿病病程、BMI、BUA、FBG、HbA1c、TG、TC、LDL、脂蛋白均与MAU呈正相关(P<0.05)。(3)Lo-gistic回归分析显示,糖尿病病程、HbA1c、TC、LDL、BUA、FBG是尿MAU的独立危险因素。结论糖尿病病程、HbA1c、TC、LDL、BUA、FBG与DN患者尿MAU排泄增加有关。 Objective To investigate related factors of microalbuminuria (MAU) in patients with diabetic nephropa- thy (DN) . Methods 377 DN patients admitted to the First Affiliated Hospital of Xinjiang Medical University in 2009 were se- lected. The general information [ gender, age, nationality, duration of diabetes, height, body mass and body mass index (BMI) ~ and laboratory examination results [uric acid (BUA), fasting plasma glucose (FBG), tfiglycerides (TG), total cholesterol ( TC), high density lipoprotein ( HDL), low density lipoprotein (LDL), glycosylated hemoglobin ( HbA,o ) and lipoprotein ~ of the patients were retrospectively analyzed. The patients were divided into low value of proteinuria group, high value of proteinuria group and very high value of proteinuria group. The above mentioned indexes of the three groups were compared and the correlation between each index and MAU was analyzed. Results ( 1 ) Compared with the low value of proteinufia group, patients in the high value of proteinuria group and very high value of proteinuria group were alder, had longer duration of disease and higher levels of BMI, FBG, BUA, TG, TC, LDL and lipoprotein, but had lower level of GFR, and the differences were statistically significant (P 〈 0. 05 ) . (2) Multiple correlation analysis showed that MAU was positively correlated with age, course of disease, BMI, BUA, FBG, HbA^c, TG, TC, LDL and lipoprotein (P 〈0. 05) . (3) Logistic regression analysis showed that course of disease, HbAlo, TC, LDL, BUA and FBG were independent risk factors for MAU. Conclusion Course of disease, HbAlo, TC, LDL, BUA and FBG are related to the increased excretion of MAU in DN patients.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第24期2755-2758,共4页 Chinese General Practice
关键词 微量清蛋白 糖尿病肾病 相关因素 Microalbuminuria Diabetic nephropathies Related factors
  • 相关文献

参考文献15

  • 1Navarro JF,Mora C,Maca M,et al.Inflammationtory parameters are independently associated with urinary albumin in type 2 diabetes mellitus[J].Am J Kidney Dis,2003,42:53-61.
  • 2Anders HJ,Vielhauer V,Schlndorff D.Chemokines and chemokine receptors are involved in the resolution or progression of renal disease[J].Kidney Into,2003,63:401-415.
  • 3Mensah-Brown EPK,Obineche EN,Galadari S,et al.Streptozotocin-induced diabetic nephropathy in rats:the role of inflammatory cytokines[J].Cytokine,2005,31(3):180-190.
  • 4高阳,陈思娇,杨红艳,李红燕,朱贺,郭英华,宋今丹.糖尿病肾病患者尿微量清蛋白与肌酐比值的相关因素研究[J].中国全科医学,2011,14(6):598-600. 被引量:41
  • 5Mogensen CE,Poulsen PL.Microalbuminuria,glycemic control,and blood pressure predicting outcome in diabetes type 1 and type 2[J].Kidney International,2004,66:S40-S41.
  • 6余堂宏,贾汝汉,丁国华,熊燕,陈健.霉酚酸酯对2型糖尿病大鼠肾脏的保护作用[J].中国临床药理学与治疗学,2004,9(10):1119-1122. 被引量:7
  • 7中华医学会糖尿病学分会糖尿病慢性并发症调查组,向红丁.全国住院糖尿病患者慢性并发症及其相关危险因素10年回顾性调查分析[J].中国糖尿病杂志,2003,11(4):232-237. 被引量:561
  • 8Adler AI,Stevens RJ,Manley SE,et al.Development and progression of nephropathy type 2 diabetes:the United Kingdom Prospective Diabetes Study(UKPDS 64)[J].Kidney Int,2003,63(l):225-232.
  • 9陈敏章 邵丙扬 王海燕 等.中华内科学[M].北京:人民卫生出版社,1999.2502.
  • 10Dirkje W,Melvin R,Joost CM,et al.Anti-inflammatory and anti-coagulant effects of pravastatin in patients with type 2 diabetes[J].Diabetes Care,2004,27:468-473.

二级参考文献16

  • 1陈清棠 主编.临床神经病学[M].北京:北京科学技术出版社,2002.178.
  • 2[2]Becker BN. Mycophenolate mofetil[J]. Transplant Proc, 1999;31(5) :2777 - 8
  • 3[3]Ziswiler R, Steinmann-niggli K, Kappeler A, Daniel C, Marti HP. Mycophenolic acid: a new approach to therapy of experimental mesangial proliferative glomerulonephritis [ J]. J Am Soc Nephrol, 1998;9(11) :2055 - 66
  • 4[5]Wahab NA, Weston BS, Robters T, Mason RM. Connective tissue growth factor and regulation of mesangial cell cycle: role in cellular hypertrophy[J]. J Am Soc Nephrol, 2002; 13 (10):2437 - 45
  • 5[6]Grotendorst GR. Connective tissue growth factor: a mediator of TGF- beta action on fibroblasts[J]. Cytokine Growth Factor Rev,1997;8(3): 171 - 9
  • 6[7]Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis [ J ]. J Am Soc Nephrol, 2000; 11(1):25-38
  • 7[8]Utimura R, Fujihara CK, Matter AL, Malheiros DM, Noronha IL, Zatz R, et al. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes[J]. Kidney Int, 2003;63(1) :209 - 16
  • 8陈思娇,祁虹,魏敏,高阳,胡怡,熊盈,李廷富.缬沙坦对高血压糖尿病合并胰岛素抵抗和勃起功能障碍患者C-反应蛋白及性功能的作用[J].中国全科医学,2007,10(18):1502-1504. 被引量:9
  • 9陈思娇,高阳,胡怡,魏敏,李强,张绍维,宋今丹.舒洛地特对早期糖尿病肾病的干预效应[J].中国临床药学杂志,2008,17(1):1-6. 被引量:10
  • 10陈思娇,高阳,胡怡,熊盈,魏敏,李强,张绍维,李恂,陈建平,宋今丹.葡糖胺聚糖对糖尿病肾病血浆内皮素及血清一氧化氮的作用[J].中国医师杂志,2008,10(4):472-475. 被引量:2

共引文献948

同被引文献55

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部